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INTRODUCTION
Eye development is a multistep process that requires specific
inductive signals and precise morphogenetic movements.
Although classical experimental embryology studies have been
fundamental to our current knowledge of eye formation (see
Spemann, 1938), it is only recently that the genetic bases
underlying this complex phenomenon have begun to be
unraveled. Integration of genetic and developmental biology
studies performed in Drosophila and vertebrates suggested that
key regulatory genes in eye development have been conserved
during evolution. Among these genes eyeless (ey), sine oculis
(so), eyes absent (eya) and dachshund (dac) appear to play
important roles in Drosophila as they have been shown to be
necessary for eye formation and sufficient, when overexpressed,
to induce ectopic eyes. Vertebrate homologues of ey (Pax6), so
(six gene family) and eya (Eya genes) have been described and,
at least in the case of Pax6 and Six3, a functional role in
vertebrate eye development has also been shown (reviewed in
Oliver and Gruss, 1997). In vertebrates, the initial function of
master regulators of eye development has probably to take place
at early neurula stage, when the presumptive eye territories are
first clearly determined. In fact, lineage tracing studies
performed in Xenopus have identified the anterior neural plate
as the region fated to give rise to the retina and the anterior brain
(Eagleson and Harris, 1990; Eagleson et al., 1995). The
expression domains of some homeobox genes appear to pattern
the Xenopus anterior neural plate already at early neurula stage.
This is the case of Xotx genes, expressed in presumptive
forebrain and midbrain regions (Kablar et al., 1996) and XBF-
1, Xdll-3 and Xemx genes (Papalopulu and Kintner, 1993, 1996;
Pannese et al., 1998), expressed in different presumptive
forebrain areas. Another restricted class of homeobox genes is
expressed in the most anterior part of the neural plate mainly
confined to the eye prospective territories. Members of this class
are the Xenopus homologues of Pax6 (Xpax6, Hirsch and
Harris, 1997; Li et al., 1997) and Six3 (Xsix3, this work) as well
as the recently isolated paired-like homeobox gene Xrx1
(Casarosa et al., 1997; Mathers et al., 1997). Identifying the
network of interactions occurring between these genes,
represents a primary goal toward the understanding of eye and
anterior brain patterning mechanisms.
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The anteriormost part of the neural plate is fated to give
rise to the retina and anterior brain regions. In Xenopus,
this territory is initially included within the expression
domain of the bicoid-class homeobox gene Xotx2 but very
soon, at the beginning of neurulation, it becomes devoid of
Xotx2 transcripts in spatiotemporal concomitance with the
transcriptional activation of the paired-like homeobox gene
Xrx1. By use of gain- and loss-of-function approaches, we
have studied the role played by Xrx1 in the anterior neural
plate and its interactions with other anterior homeobox
genes. We find that, at early neurula stage Xrx1 is able to
repress Xotx2 expression, thus first defining the retina-
diencephalon territory in the anterior neural plate.
Overexpression studies indicate that Xrx1 possesses a
proliferative activity that is coupled with the specification
of anterior fate. Expression of a Xrx1 dominant repressor
construct (Xrx1-EnR) results in a severe impairment of eye
and anterior brain development. Analysis of several brain
markers in early Xrx1-EnR-injected embryos reveals that
anterior deletions are preceded by a reduction of anterior
gene expression domains in the neural plate. Accordingly,
expression of anterior markers is abolished or decreased in
animal caps coinjected with the neural inducer chordin and
the Xrx1-EnR construct. The lack of expansion of mid-
hindbrain markers, and the increase of apoptosis in the
anterior neural plate after Xrx1-EnR injection, indicate
that anterior deletions result from an early loss of anterior
neural plate territories rather than posteriorization of the
neuroectoderm. Altogether, these data suggest that Xrx1
plays a role in assigning anterior and proliferative
properties to the rostralmost part of the neural plate, thus
being required for eye and anterior brain development.
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We previously showed that Xrx1 expression is first activated
at the early neurula stage in the anterior neural plate by vertical
signals from the dorsal mesoendoderm. Later on, Xrx1
transcripts are detected in the neural structures of the
developing eye and other anterior neural plate derivatives such
as the pineal gland, the diencephalon floor and the hypophysis
(Casarosa et al., 1997). Functional studies on this gene have
shown that its overexpression in Xenopus results in ectopic
retinal and neural tissue formation, while mouse embryos
carrying a null allele of the Xrx1 murine homologue, lack optic
cups and display a reduction of brain structures (Mathers et al.,
1997). Nevertheless, until now the functional relationship
between Xrx1 and other homeobox genes in patterning the
anterior neural plate has not been investigated.
In the present work, we address the early role of Xrx1 and
regulatory interactions occurring between Xrx1 and other
anterior homeobox genes, making use of gain- and loss-of-
function approaches available in the Xenopus system.
Overexpression experiments, including analysis of anterior
markers, indicate that Xrx1 proliferative activity is linked to the
specification of anterior fate. Inactivation of Xrx1 function,
performed microinjecting RNA encoding a Xrx1 engrailed
repressor fusion protein (Xrx1-EnR), leads to a remarkable
reduction of anterior neural plate territories, as judged by the
expression of several anterior markers, causing a failure in eye
and anterior brain formation. Analysis of apoptosis and
hindbrain markers expression indicate that these effects are due
to an early loss of anterior territories rather than a
posteriorization of the neuroectoderm. Finally, we propose that
Xrx1 plays an early role defining prosencephalic territories in
combination with Xotx2, Xpax6, Xsix3 and XBF-1 in the
anterior neural plate.
MATERIALS AND METHODS
Embryos and histology
Induction of ovulation of females, in vitro fertilisation and embryo
culture were carried out as described by Newport and Kirschner
(1982). Staging was according to Nieuwkoop and Faber (1967).
Histological examination was performed according to Casarosa et al.
(1997).
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed on staged embryos,
as well as on animal caps, essentially as described by Harland (1991).
The antisense or control sense-strand RNA probes from Xotx2
(Pannese et al., 1995), XAG-1 (Sive et al., 1989), XBF-1 (Papalopulu
and Kintner, 1996), Krox20 (Bradley et al., 1993), En2 (Hemmati-
Brivanlou et al., 1991), gsc (Cho et al., 1991) and Xotx-b (kindly
provided by Dr R. Harland) were generated from linearized plasmids
using either digoxigenin or fluorescein RNA labelling mix
(Boehringer).
For double whole-mount in situ hybridization, the embryos were
hybridized with both probes at the same time under standard
conditions. After detection of the first probe with BM purple
(Boehringer), the alkaline phosphatase was inactivated in 100 mM
glycine pH 2.2, 0.1% Tween-20 and the embryos blocked in MAB
(100 mM maleic acid, 150 mM NaCl), 2% Boehringer blocking
reagent and 20% heat-inactivated sheep serum. Following incubation
with the second antibody, the alkaline phosphatase reaction was
performed with Magenta-Phos (Sigma). In some cases (Fig. 1M-O),
RNA encoding for b -galactosidase containing a nuclear localization
signal was used as a tracer.
Preparation of constructs and PCR cloning
Capped sense Xrx1 RNA was generated from T7TS-Xrx1 clone
consisting of the full-length Xrx1 cDNA cloned in the expression
vector T7TS. Capped antisense RNA for Xrx1 was prepared from
CS2-ASXrx1 obtained subcloning the full-length cDNA into CS2+
vector (Rupp et al., 1994).
The Xrx1 construct lacking the OAR domain (D OAR) was prepared
subcloning the AvaII fragment from T7TS-Xrx1 into CS2+ plasmid.
The Xrx1-EnR construct was prepared subcloning the AvaII fragment
from T7TS-Xrx1 in frame with the Drosophila engrailed repressor
sequence (amino acids 1-296) contained in ENG-N vector (a kind gift
of Dr Dan Kessler). Xsix3, Xpax2 and Xpax6 were cloned by RT-PCR
from Xenopus stage 19 RNA. PCR products were subcloned using a
pGEM-T vector system (Promega). Degenerate primers used for Xsix3
amplification were designed based upon the amino acid sequences
WPPGACEA and AMWLEAHYQ, which are specifically found only
in mouse Six3 and not in other members of the Six family. Over the
amplified region, Xsix3 predicted amino acid sequence was 100%
identical to zebrafish Six3 (Seo et al., 1998) and 97% to mouse (Oliver
et al., 1995) and chick (Bovolenta et al., 1998) Six3. For Xpax2
amplification, degenerate primers based upon the evolutionary
conserved Pax2 amino acid sequences IIRTKVQQ and YPTSTLAG
were used. Xpax2 amplified region was identical to the Xpax-2a (3)
nucleotide sequence described by Heller and Brandli (1997).
Similarly, Xpax6 was amplified using degenerate primers
corresponding to the Pax6 evolutionary conserved amino acid
sequences NLASEKQQ and QIEALEKE. Xpax6 amplified region
was found to be identical to Xenopus Pax6 nucleotide sequence
deposited in GenBank by Hollemann, Bellefroid and Pieler, GenBank
accession number U67887.
Embryo microinjections and animal cap assay
Capped synthetic RNAs were generated by in vitro transcription of
CS2-ASXrx1, T7TS-Xrx1, D OAR, Xrx1-EnR, T7TS-Xotx2 (Pannese
et al., 1995) and chordin (Sasai et al., 1995). Xpax6 capped RNA was
transcribed from P6mycS (Hirsch and Harris, 1997), a generous gift
of Dr William Harris, and its activity was tested by the ability to
induce ectopic b -B1 crystallin expression (not shown, see Altman et
al., 1997). Embryo microinjections were performed as described in
Andreazzoli et al. (1997). Animal caps were dissected out of stage 8-
9 embryos in 1 · MBS and, after healing, they were cultured in 0.5·
MBS. When sibling control embryos reached stage 12.5, animal caps
were fixed and stored in ethanol at - 20°C.
TUNEL staining
Whole-mount TUNEL staining was performed as described in Hensey
and Gautier (1998).
RESULTS
Effects of Xrx1 RNA microinjection on the
expression of anterior genes
Xrx1 is expressed in the anterior neural plate at the end of
gastrulation and subsequently in the neural structures of the
developing eye and other forebrain structures derived from the
anterior neural plate (Casarosa et al., 1997; Mathers et al.,
1997). This expression pattern raises the question whether
Xrx1 plays a role in the specification of anterior neural plate
regions and structures that derive from it. As a first approach
to study the role of Xrx1 during development, we
overexpressed this gene by microinjection of its capped RNA
into single blastomeres of 2-, 4- and 8-cell stage Xenopus
embryos. We found that tadpoles developed from embryos
injected, at 8-cell stage, into a dorsal animal blastomere, which
M. Andreazzoli and others
2453Xrx1 in anterior neural plate patterning
is fated to give rise to dorsoanterior regions of the embryo
(Huang and Moody, 1993), very frequently show the presence
of ectopic pigmented epithelium (Fig. 1A,B; Table 1) often
associated with an overproliferating neural retina and neural
tube (Fig. 1C and data not shown), in agreement with the work
done by Mathers et al. (1997). Despite of a broader distribution
of the injected RNA, the ectopic pigmented epithelium and
neural tissue are always localized in a region comprising tissue
between the eye and the brain. This area derives from a region
of the anterior neural plate that is initially competent to become
retina but this fate is later suppressed by signals coming from
the prechordal plate (Li et al., 1997). These observations raise
the possibility that Xrx1 may be able to exert its function only
in a spatially restricted area because it needs to interact with
other eye-brain-specific transcription factors. For this reason,
we analyzed the expression of several anterior genes in Xrx1-
injected embryos at early neurula (stage 13) and tailbud (stage
24) stages.
Embryos injected with Xrx1 RNA in a dorsal-animal
blastomere at 8-cell stage were analyzed at later stages by
double whole-mount in situ hybridization using as probes
digoxigenin-labelled antisense RNA for the gene of interest,
together with fluorescein-labelled antisense Xrx1 RNA. This
allowed us to detect both the distribution of injected Xrx1 RNA
(magenta staining) and the expression of the gene that we
wanted to test (blue staining). Since the signal given by
hybridization of Xrx1 antisense probe with the injected RNA
was stronger and appeared much earlier than endogenous Xrx1
signal, the staining reaction could be stopped when only
injected Xrx1 RNA was detected.
Analysis of Xpax6 expression in Xrx1-injected embryos
showed that, while at stage 13 the expression of this gene does
not appear to be affected (77% normal expression, 23% slightly
reduced expression, n=93; Fig. 1D), an effect is observed at
stage 24. At this later stage, Xpax6 normal expression, which
can be seen in the uninjected control side of the embryos, is
detected in the optic vesicle, forebrain, hindbrain and spinal
cord with a characteristic gap of expression in the midbrain
(Fig. 1F). Interestingly, inspection of the injected side of the
embryos revealed that Xpax6 expression had expanded dorsally
to the eye vesicle, thus filling the gap (67%, n=30; Fig. 1E).
A similar response to Xrx1 overexpression was observed
analyzing Xsix3 expression. As in the case of Xpax6, Xsix3
expression did not appear to be affected at early stage (100%,
n=35; Fig. 1G) while it was expanded at tailbud stage (54%,
n=28; Fig. 1H). Xsix3 ectopic expression is observed as a
dorsal expansion of the eye expression domain of this gene.
Xotx2 displays a dynamic pattern of expression during early
development. At the end of gastrulation (stage 12), Xotx2 is
Fig. 1. Effects of Xrx1 overexpression. (A-C) Embryos microinjected
with Xrx1 RNA in the right dorsoanimal blastomere at 8-cell stage.
The arrows point to ectopic pigmented retina located between eye
and diencephalon. (B,C) Transverse sections of an embryo similar to
the one shown in A; (B) a section where the ectopic pigmented retina
is visible (arrow); (C) a more posterior section where the duplication
of the neural tube becomes evident (arrowhead). (D-O) Whole-mount
in situ hybridization analysis of embryos microinjected with Xrx1
RNA at 8-cell stage in one dorsoanimal blastomere. (D-K¢ ) The
staining pattern of the gene of interest (blue) on the injected side (i)
should be compared with that on the uninjected control side (c). In
the same panels, the distribution of Xrx1-injected RNA is visualized
by cohybridization with Xrx1 antisense RNA revealed by magenta
staining. (M-O) Nuclear b -gal RNA has been used as a tracer and the
b -galactosidase activity is represented by the red staining.
(D-F) Expression of Xpax6 (blue) in Xrx1-injected embryos.
(D) Xpax6 expression at stage 13 is not significantly affected by Xrx1
overexpression; (E,F) Xpax6 expression in the injected and control
side of a stage 23 embryo, respectively. Note that the normal Xpax6
gap of expression in the midbrain present in the control side (area
between lines) has been filled by ectopic Xpax6 expression in the
injected side of the embryo. (G-I) Expression of Xsix3 (blue) in
Xrx1-injected embryos. (G) Expression of Xsix3 at stage 13 is not
affected by Xrx1 RNA injection. (H,I) Xsix3 expression in the
injected and control side of a stage 23 embryo, respectively. The eye
expression of Xsix3 in the injected side appears expanded
dorsoposteriorly when compared to the control side.
(J,K,K ¢ ) Expression of Xotx2 (blue) in Xrx1-injected embryos.
(J) Expression of Xotx2 at stage 13 is repressed by Xrx1
overexpression. (K,K¢ ) Examples of Xotx2 expression in stage 23
Xrx1-injected embryos where Xotx2 expression is extended laterally
(K) or posteriorly (K¢ ) in the injected side. The white line marks the
posterior boundary of Xotx2 expression in the control side.
(L) Double whole-mount in situ hybridization performed on a stage
13 normal embryo showing the complementarity of Xrx1 (magenta)
and Xotx2 (blue) expression domains. (M,N) Expression of XAG-1
(blue) in Xrx1-injected embryos. (M) Expression of XAG-1 is
repressed at stage 13 by Xrx1 overexpression. (N) XAG-1 is
ectopically activated in the injected side of a stage 23 embryo.
(O) Expression of XBF-1 (blue) in Xrx1-injected embryos at stage
13. XBF-1 expression is expanded laterally on the injected side.
2454
expressed in all the presumptive anterior neuroectoderm but
subsequently (stages 12.5-13) its expression appears to be
repressed in the most anterior part of the neural plate (Pannese
et al., 1995; Kablar et al., 1996). In order to define the
relationship between territories expressing Xotx2 and Xrx1 at
early neurula stage, we performed a double in situ
hybridization. As can be seen in Fig. 1L, the two genes show
complementary expression domains with Xrx1 being activated
in the place and time corresponding to Xotx2 repression. Xrx1
and Xotx2 expression domains remain almost completely
mutually exclusive for most of neurulation but at tailbud stage,
because of Xotx2 activation in the eye vesicles and in the
diencephalon, the two expression domains largely overlap. In
agreement with the observed concomitance between
appearance of Xrx1 transcripts and downregulation of Xotx2 at
early neurula stage, we found that Xrx1 overexpression is able
to repress Xotx2 at this same stage (95%, n=60; Fig. 1J).
However, at tailbud stage, Xotx2 shows a different response to
Xrx1 overexpression, being ectopically activated (53%, n=68)
laterally (Fig. 1K) or dorsally (Fig. 1K¢ ). A similar effect is
observed for the cement-gland-specific marker XAG-1, which
is repressed by Xrx1 overexpression at early neurula stage
(78%, n=45; Fig. 1M) but ectopically activated at tailbud stage
(67%, n=42; Fig. 1N). The early repressive effects of Xrx1 on
Xotx2 and XAG-1 find a correlation with the spatial relationship
between the expression domains of these three genes in the
early neurula. On the contrary, the later ectopic expression of
Xpax6, Xsix3 and Xotx2 coincides with the area where the
hyperproliferative activity of injected Xrx1 takes place (see Fig.
1A-C and data not shown) and should be considered an
attribute of the proliferated tissue. The anterior character of the
proliferating tissue is also confirmed by the late ectopic
activation of XAG-1. This gene, which is known to be inducible
by Xotx2 (Andreazzoli et al., 1997; Gammill and Sive, 1997),
has only been found ectopically expressed in the anterior
ventrolateral ectoderm, in keeping with the observation that
dorsal ectoderm is not competent to form cement gland
(Gammill and Sive, 1997). We also analyzed the expression of
XBF-1, an early marker of the presumptive telencephalon, in
Xrx1-injected embryos. Ectopic activation of XBF-1 at early
neurula stage is observed to expand laterally, seemingly along
the border of the neural plate (65%, n=20; Fig. 1O). Another
gene that we analyzed, because of its interesting expression
pattern, was Xpax2. At stage 24, Xpax2 major expression sites
in the head region are the ventral optic vesicles, otic vesicles
and midbrain-hindbrain boundary. While Xrx1 overexpression
does not affect the ventral optic vesicle domain and, in some
cases, only slightly reduces Xpax2 expression in the otic
vesicle, a strong repressive effect is observed in the midbrain-
hindbrain expression domain (83%, n=24; Fig. 2A,B). In order
to see if this effect was restricted to Xpax2, we analysed the
expression of En2, which is also specifically expressed in the
midbrain-hindbrain boundary. As shown in Fig. 2C, En2
expression is also repressed by Xrx1 overexpression (85%,
n=26). To extend this analysis to the hindbrain, we used Krox20
as a marker and found that, in Xrx1-injected embryos, Krox20
expression in rhombomere 3 was almost totally suppressed
while expression in rhombomere 5 was only reduced (100%,
n=20; Fig. 2D). No significant change in spinal cord expression
of Xpax6 and Xpax2 was observed (Fig. 1D,E and data not
shown) suggesting that the effects of Xrx1 overexpression do
not extend to the posterior nervous system.
Inactivation of Xrx1 function
As a complementary study to analyse Xrx1 function during
embryogenesis, we used different approaches with the aim of
generating a functional inactivation of this gene. To this
purpose, we first used a method that utilizes the microinjection
of capped antisense RNA (Steinbeisser et al., 1995; Epstein et
al., 1997). We observed an effect microinjecting Xrx1 antisense
RNA in a dorsal-animal blastomere at 8-cell stage, only when
the dose of injected RNA reached 1100 pg. In this case, about
a quarter of injected embryos displayed anterior deficiencies
that ranged from reduced eyes to more severe suppression of
anterior head development (Table 1). Further increase in the
amount of microinjected RNA only led to various aspecific
defects in embryo development.
As a second approach, we microinjected the embryos with
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Table 1. Effects of microinjection of Xrx1 constructs and rescue experiments
% ectopic
RNA inject. pigmented % reduced % anterior % minor % normal
(pg) n Stage epithelium eyes reductions defects embryos
Xrx1 242 1DA/8C 60 0 0 3 37
350
Xrx1 antisense RNA 70 1DA/8C 0 17 6 0 77
1100
D OAR 72 2DA/8C 0 29 3 10 58
400
Xrx1-EnR 118 2DA/8C 0 52 28 0 20
400
Xrx1-EnR+Xrx1 151 2DA/8C 28* 12 2 4 54
400+600
Xrx1EnR+Xpax6 220 2DA/8C 0 60‡ 36‡ 0 4
400+150
Xrx1-EnR+Xotx2 121 2DA/8C 0 50‡ 40‡ 0 10
400+600
Uninjected 520 0 0 0 3 97
RNAs were injected into one or two dorsal-animal blastomeres at 8-cell stage, indicated as 1DA/8C and 2DA/8C, respectively.
*These embryos were composed by 33% embryos with eyes of regular size and 67% embryos displaying slight eye reduction.
‡These embryos also displayed posterior deficiencies.
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RNA generated from a construct ( D OAR) lacking the putative
transactivation domain of Xrx1 (Fig. 3A). Expression of similar
truncated proteins has been shown to cause a passive repression
of target genes (Jaynes and O’Farrell, 1991; Epstein et al.,
1997). Although transactivation domains have not been
functionally mapped in any of the homologues of Xrx1,
sequence comparison analysis revealed the presence of an
amino acid motif, located at the carboxy-terminus, conserved
between proteins of the Rx family and other paired-like
homeodomain proteins (Furukawa et al., 1997). Since this
motif, which was named OAR domain, acts as a transcriptional
activation domain in Orthopedia protein (Simeone et al., 1994),
we reasoned that it could play a similar role in Xrx1 as well.
Microinjection of D OAR RNA did not produce any of the
effects described for wild-type Xrx1 overexpression, while
about one third of the injected embryos showed the same
anterior defects observed in Xrx1 antisense injection
experiments (Table 1).
Looking for a more efficient way of inactivating Xrx1
function, we prepared a construct encoding a chimeric protein
in which the truncated form of Xrx1 lacking the OAR domain
was fused in frame with the repressor domain of Drosophila
engrailed (Xrx1-EnR, Fig. 3A). Embryos obtained after
microinjection of RNA generated from this construct, showed
strongly underdeveloped or, in extreme cases, absent eyes
often associated with a reduction of anterior brain (Fig. 3B).
These phenotypes closely resemble those obtained after
microinjection of Xrx1 antisense or D OAR RNAs with the
difference that the frequency of affected embryos in the case
of Xrx1-EnR injection was much higher (Table 1). To test if
Xrx1-EnR specifically antagonises Xrx1 function, we
coinjected both transcripts in dorsoanimal blastomeres at 8-
cell stage. About 70 % of coinjected embryos showed a
complete or partial rescue of eye and anterior head structures
(Fig. 3C; Table 1). As already described for this kind of
rescue experiments (Conlon et al., 1996; Isaacs et al., 1998),
in many cases the effects of Xrx1 overexpression became
evident before the Xrx1-EnR anterior defects were completely
rescued. This resulted in embryos displaying slightly reduced
eyes together with ectopic pigmented retina (Fig. 3C). We
also tested if Xotx2 or Xpax6, two genes involved in eye and
anterior brain development, were able to rescue Xrx1-EnR
phenotype. We found that neither Xotx2 nor Xpax6 could
substitute for Xrx1 and rescue Xrx1-EnR defects (data not
shown). As a matter of fact, embryos coinjected with Xrx1-
EnR and Xotx2 or Xpax6 showed both anterior deficiencies
and posterior defects, the latter being typical of Xotx2 and
Xpax6 overexpression (Pannese et al., 1995; Hirsch and
Harris, 1997). Therefore these data suggest that Xrx1-EnR
specifically interferes with endogenous Xrx1 binding to target
genes.
Both inspection of external morphology and histological
examination (data not shown) suggested that the inactivation
of Xrx1 leads not only to the lack of optic vesicles, but also to
deletion of telencephalic regions where the gene is not
expressed at late stages. This prompted us to check if at early
stages Xrx1 was expressed in telencephalic presumptive
regions. Overlapping of Xrx1 and XBF-1 expression domain at
stage 12.5 revealed that, indeed, Xrx1 expression encompasses
also presumptive telencephalic territories at early neurula stage
(Fig. 3D,E).
Xrx1-EnR RNA microinjection leads to reduced
expression domains of anterior neural plate markers
In order to better define these phenotypes, embryos injected
with Xrx1-EnR RNA in both dorsoanimal blastomeres at 8-cell
stage were examined for alterations in the expression of several
anterior markers (Fig. 4). At stage 13, the anterior expression
domains of Xotx2, Xpax6 and Xsix3 appeared to be remarkably
reduced in size and, in some instances, also in intensity (Xotx2,
100%, n=26; Xpax6, 100%, n=24; Xsix3, 100%, n=28; Fig.
4B,F,J) compared to control uninjected embryos (Fig. 4A,E,I).
XBF-1 expression, which at stage 13 labels the presumptive
telencephalon (Papalopulu and Kintner, 1996; Fig. 4M), is
either strongly repressed or completely suppressed (50% with
reduced expression, 50% with no expression, n=18; Fig. 4N
and data not shown). Our interpretation of these data (see
Discussion) is that Xrx1 is required for proper formation of
anterior neural plate territories and that this has a bearing on
the phenotypes and gene expression patterns observed at
tailbud stage for Xrx1-EnR-injected embryos. Analysis of
Xsix3 expression at stage 24 showed that optic vesicles
expression was absent, while a residual forebrain expression
probably corresponding to the diencephalon was still detected
(100%, n=32; Fig. 4L). Similarly, at this later stage, Xpax2
optic vesicles expression was repressed while expression
domains corresponding to midbrain-hindbrain boundary, otic
vesicles, hindbrain and spinal cord were still present (100%,
n=18; Fig. 4P). In the case of Xpax6, besides expression in the
spinal cord, only a residual signal is found in the most anterior
dorsal region of the embryo, while no obvious optic vesicles
expression is detectable (100%, n=18; Fig. 4H). Stage 24 Xotx2
expression domain also appeared to be spatially reduced in the
anterior part (100%, n=16; Fig. 4D) compared to control
embryo (Fig. 4C). Nevertheless, the posterior boundary of
expression, corresponding to the posterior end of the midbrain,
appeared to be sharply defined as it is in normal embryos. A
very similar pattern was also observed in Xrx1-EnR-injected
embryos hybridized with Xotx1, a gene that shares with Xotx2
the same posterior boundary of expression (data not shown).
Since expression analysis of Xpax6, Xsix3, Xotx2 and Xotx1 in
Xrx1-EnR-injected embryos suggests that some region anterior
to the rhomboencephalon-mesencephalon boundary are
present in these embryos, we tested the presence of a
diencephalic marker. We used Xotx-b (gift of Dr Harland)
which at stage 24 is expressed primarily in the pineal gland
(Fig. 4S). As shown in Fig. 4T, Xotx-b is expressed in Xrx1-
EnR-injected embryos, although at lower level compared to
control embryos (100%, n=15), thus indicating that at least part
of dorsal diencephalon is present. We then asked whether the
anterior deletion observed upon inactivation of Xrx1 function
may reflect a reduction of the anterior mesoendoderm. Using
goosecoid (gsc) as a marker of this region (Cho et al., 1991),
we did not observe any significant difference in gsc expression
comparing Xrx1-EnR-injected and control embryos (Fig. 4Q,R;
Xrx1-EnR-injected embryos, 84% normal expression, 16%
slightly reduced expression; n=51).
Xrx1-EnR activity in chordin-injected animal caps
In order to study the activity of Xrx1-EnR in a simplified
system that could mimic the anterior neural plate, we analyzed
the effects of Xrx1-EnR in animal caps neuralized by chordin
(Sasai et al., 1995) RNA microinjection. For this analysis we
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focused on the expression of XBF-1, Xpax6 and Xotx2, which
are among the genes whose expression domain is reduced by
Xrx1-EnR injection already at early neurula stage. As expected
from the described forebrain-like neuralization induced by
chordin, we found that all these anterior genes are activated in
chordin-injected caps (Fig. 5A-C; 100% positive in all cases,
XBF-1, n=26; Xpax6, n=24; Xotx2, n=27), while no expression
was detected in uninjected control caps (0% in all cases, XBF-
1, n=18; Xpax6, n=15; Xotx2, n=15; not shown). Coinjection
of chordin and Xrx1-EnR leads to a strong suppression of XBF-
1 (Fig. 5D; 88% negative, 12% weak positive; n=42) and
Xpax6 (Fig. 5E; 75% negative, 25% weak positive; n=36)
expression but only to a moderate inhibition of Xotx2 activation
(Fig. 5F; 76% positive, 18% weak positive, 6% negative;
n=38). It is worth noting that XBF-1, which is the most affected
gene by Xrx1-EnR in animal caps, is also the only gene whose
expression is completely abolished in 50% of Xrx1-EnR-
injected embryos.
Causes for anterior truncations in Xrx1-EnR-injected
embryos
The anterior truncations observed in Xrx1-EnR-injected
embryos could be due to a posteriorization of the anterior
neuroectoderm or, alternatively, to an early loss of anterior
territories. To distinguish between these two possibilities, we
performed two series of experiments. In the first set of
experiments, we asked whether hindbrain territories were
enlarged as a consequence of posteriorization in Xrx1-EnR-
injected embryos comparing the expression domains of En2
and Krox20 in injected and control embryos at tailbud stage.
As shown in Fig. 6, the expression domains of En2 and Krox20
in Xrx1-EnR-injected embryos (Fig. 6B,D, respectively) do not
appear to differ significantly in size and shape (En2, 88%
normal expression, 12% slightly reduced expression; n=42;
Krox20, 87% normal expression, 13% slightly reduced
expression; n=40) from those of uninjected control embryos
(Fig. 6A,C, respectively). In the second set of experiments, we
looked at the rate of apoptosis occurring in injected and control
embryos making use of the TUNEL technique. For best
comparison, embryos were analyzed at stage 12 when
apoptosis, normally occurring during development, is at low
levels especially in the prospective anterior neural plate
(Hensey and Gautier, 1998). At this stage, Xrx1-EnR-injected
embryos showed an accumulation of apoptotic nuclei in the
anteriormost part of the embryo mainly corresponding to the
presumptive anterior neuroectoderm (87% with exclusively
anterior signal, 13% with also some dorsally sparse signal;
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Fig. 3. Effects of Xrx1-EnR RNA microinjection on eye and anterior
head development. (A) Schematic diagrams of Xrx1 constructs used
in microinjection experiments. The homeodomain (Hd), OAR
domain (OAR) and engrailed repressor domain (EnR) are indicated
as well as the amino- and carboxy-termini of the proteins (N and C,
respectively). (B) Stage 41 embryos resulting from microinjection of
400 pg Xrx1-EnR RNA in both dorsoanimal blastomeres at 8-cell
stage. The top embryo is an uninjected control. (C) Xrx1 rescues the
Xrx1-EnR phenotypes. Embryos were coinjected with 400 pg of
Xrx1-EnR RNA and 600 pg of Xrx1 RNA per blastomere in both
dorsoanimal blastomeres at 8-cell stage and analyzed at stage 41.
(D,E) Expression of Xrx1 in presumptive forebrain regions of stage
12.5 normal embryos. (D) Double whole-mount in situ hybridization
with Xrx1 (magenta) and the forebrain-specific marker XBF-1 (blue).
Xrx1 expression partially overlaps with that of XBF-1. (E) Control
embryo hybridized with Xrx1 alone (blue).
Fig. 2. Effects of Xrx1 RNA microinjection in one blastomere at 8-
cell stage on Xpax2, En2 and Krox20 expression. The staining
pattern of the gene of interest (blue) on the injected side (i) should be
compared with that on the uninjected control side (c). The
distribution of Xrx1-injected RNA is visualized by cohybridization
with Xrx1 antisense RNA (magenta staining). (A,B) Expression of
Xpax2 in stage 23 Xrx1-injected embryos. (A) Frontal view showing
repression of Xpax2 expression in the midbrain-hindbrain boundary
but not in ventral optic vesicles; the dorsal side of the embryo is on
the top. (B) Dorsal view of another embryo showing strong
repression in the Xpax2 midbrain-hindbrain expression domain and a
weak reduction of the otic vesicle domain. (C) Repression of En2
expression in a stage 24 Xrx1-injected embryo. (D) Expression of
Krox20 in a stage 24 Xrx1-injected embryo. Krox20 expression at the
level of rhombomere 5 appears to be reduced while rhombomere 3
expression domain is almost completely abolished. (B-D) The
anterior part of the embryo is oriented to the left.
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Fig. 4. Effects of Xrx1-EnR RNA microinjection in both
dorsoanterior blastomeres at 8-cell stage on the expression
of anterior genes. (A-D) Embryos analyzed for Xotx2
expression. (A,C) Dorsoanterior and lateral views of the
normal expression in stage 13 and stage 24 embryos,
respectively. (B,D) Dorsoanterior and lateral views of
embryos at stage 13 and 24, respectively, injected with
Xrx1-EnR RNA. (E-H) Embryos analyzed for Xpax6
expression. (E,G) Dorsoanterior and lateral views of the
normal expression in stage 13 and stage 24 embryos,
respectively. (F,H) Dorsoanterior and lateral views of
embryos at stage 13 and 24, respectively, injected with
Xrx1-EnR RNA. (I-L) Embryos analyzed for Xsix3
expression. (I,K) Dorsoanterior and frontal views of the
normal expression in stage 13 and stage 24 embryos,
respectively. (J,L) Dorsoanterior and frontal views of
embryos at stage 13 and 24, respectively, injected with
Xrx1-EnR RNA. (M,N) Embryos analyzed at stage 13 for
XBF-1 expression (dorsoanterior views). (M) Control
uninjected embryo. (N) Embryo injected with Xrx1-EnR
RNA. (O,P) Embryos analyzed at stage 24 for Xpax2
expression (lateral views). (O) Control uninjected embryo.
(P) Embryo injected with Xrx1-EnR RNA. Arrows indicate
Xpax2 expression domain corresponding to the midbrain-
hindbrain boundary. (Q,R) Embryos analyzed at stage 12.5
for gsc expression (dorsal views). (Q) Control uninjected
embryo. (R) Embryo injected with Xrx1-EnR RNA.
(S,T) Embryos analyzed at stage 24 for Xotx-b expression
(lateral views). (S) Control uninjected embryo. (T) Embryo
injected with Xrx1-EnR RNA. Arrowheads indicate Xotx-b
expression in the pineal gland.
Fig. 5. Coinjection of chordin and Xrx1-EnR in
animal caps. (A-C) Animal caps dissected from
embryos microinjected with chordin RNA.
(D-F) Animal caps dissected from embryos
coinjected with chordin and Xrx1-EnR RNAs. The
probes used were XBF-1 (A,D), Xpax6 (B,E) and
Xotx2 (C,F).
Fig. 6. (A-D) En2 (A,B) and Krox20 (C,D) expression in
uninjected (A,C) and Xrx1-EnR-injected embryos (B,D),
as observed at stage 28. (E-G) TUNEL staining in stage
12 embryos. Dorsal-anterior (E) and lateral (F) views of
Xrx1-EnR-injected embryos are shown. (G) Dorsal-
anterior view of a control uninjected embryo. In E and
G, posterior is to the top and anterior to the bottom. In F,
dorsal is to the top and anterior to the left.
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n=39; Fig. 6E,F). No significant signal was observed in control
uninjected embryos (Fig. 6G). Together with the reduction of
expression of anterior markers (Fig. 4), these data suggest that
anterior deficiencies of Xrx1-EnR-injected embryos are due to
an early loss of anterior neural plate territories rather than a
transformation of anterior neuroectoderm into more posterior
neural areas.
DISCUSSION
In this study, making use of gain- and loss-of-function
approaches, we aimed at better understanding the role of the
paired-like homeobox gene Xrx1 and its relationships with
other homeobox genes in the establishment and patterning of
the anterior neural plate.
Homeobox genes in early anterior neural plate
patterning
One of the earliest genes to be expressed in the presumptive
anterior neuroectoderm already at the end of gastrulation is the
bicoid-class homeobox gene Xotx2. This gene shows a
dynamic expression in this region being repressed in the
anteriormost part of the neural plate at the beginning of
neurulation. We noticed that this anterior repression of Xotx2
coincides spatially and temporally with the first appearance of
Xrx1 transcripts and, in fact, a double whole-mount in situ
hybridization showed an almost complete complementarity
between the expression pattern of these two genes at stage 12.5.
At this time, Xrx1 is also expressed in presumptive
telencephalon where it overlaps with the expression of XBF-1
and partially with that of Xotx2. Thus, different combinations
of gene expression appear to pattern the anterior neural plate
and define specific territories. The area expressing Xrx1 but
neither Xotx2 nor XBF-1 is fated to give rise to retina and
diencephalon territories (Eagleson and Harris, 1990; Eagleson
et al., 1995). Even if not perfectly overlapping with Xrx1,
Xpax6 and Xsix3 are also expressed in this region. The neural
plate area where Xrx1, XBF-1 and Xotx2 are coexpressed
corresponds to the presumptive telencephalon while, ventrally
to Xrx1 expression domain, the cement gland presumptive
region is marked by the expression of XAG-1 and, in part,
Xotx2. The lack of apparent activation of Xpax6 and Xsix3 by
Xrx1 overexpression in stage 13 embryos may suggest that
these two genes are not downstream of Xrx1 at least at this
stage, although other explanations cannot be formally excluded
(see Discussion in the following section). Moreover, the
inability of injected Xpax6 RNA both to rescue the Xrx1-EnR
phenotypes and to modify Xrx1 expression (data not shown)
seems to indicate that Xpax6 and Xrx1 play non redundant
functions in early head development even if occurrence of such
interactions at later stages cannot be rigorously ruled out (see
next section).
In our overexpression experiments, we found that Xrx1 is
able to repress Xotx2 and XAG-1 at early neurula stage. This
suggests that Xrx1 plays an active role in repressing Xotx2
expression in the anteriormost region of the neural plate and,
possibly through this activity, in setting the dorsal border of
XAG-1 expression. There is also evidence that Xrx1might be
important to the XBF-1 activation. This is suggested by the
strong inhibition of XBF-1 expression carried out by Xrx1-EnR
in both chordin-injected caps and in early neurula embryos, as
well as by the ectopic activation of XBF-1 in Xrx1-injected
embryos. Such ectopic activation seems to coincide with the
lateral-anterior neural plate border. The inability of Xrx1 to
ectopically activate XBF-1 elsewhere in the neural plate may
indicate that other factors are required to promote XBF-1
expression during normal development and/or that inhibiting
factors prevent the expansion of XBF-1 expression in other
regions of the neural plate.
Effects of Xrx1 overexpression suggest a linkage
between proliferation and anterior fate specification
Regions of the anterior neural plate, where Xrx1 is expressed,
are also characterized by a prolonged proliferative period,
undergoing neurogenesis with a remarkable delay compared to
the posterior neural plate (Papalopulu and Kintner, 1996).
Overexpression experiments have shown that Xrx1 is able to
induce hyperproliferation of the neural tube, neural retina and
retinal pigmented epithelium (Fig. 1A-C; Mathers et al., 1997),
suggesting that Xrx1 may be responsible for some of the
proliferative properties of the anterior neural plate. When the
expression of various neuroectodermal markers in Xrx1-
injected embryos was analyzed at tailbud stage, the anterior
genes Xpax6, Xsix3 and Xotx2 were found to be ectopically
activated in the proliferating area. This ectopic activation is not
appreciable at early neural stage, suggesting the existence of
stage-dependent differences in Xrx1 activity. For example, in a
very speculative scheme, the concentration of Xrx1 at early
neurula might be above a threshold level required to support
the intensive neural plate proliferation (Eagleson et al., 1995),
thus rendering Xrx1 overexpression partly ineffective; on the
contrary, the subsequent decrease in the proliferation rate
(Eagleson et al., 1995) could be counteracted by Xrx1
overexpression, as observed at tailbud stage. A particular case
is represented by Xotx2 and its indirect target gene XAG-1,
which are both repressed at early neurula and ectopically
activated at tailbud stage. These effects might reflect Xrx1
activity in anterior neural plate patterning, as discussed in the
previous section. Accordingly, the abnormal XAG-1
expression, which is restricted to the ventral-anterior region in
keeping with the lack of competence of the dorsal side to form
cement gland (Gammill and Sive, 1997), could be seen as a
consequence of an early XAG-1 repression by the
microinjected Xrx1, which would lead to a split cement gland
field; however, this hypothesis would not explain the
occurrence of ectopic spots of XAG-1 expression located
outside the cement gland field. Alternatively, the abnormal
expression of XAG-1 might be explained as promoted by the
anterior overproliferating tissue, which also expresses the
cement gland inducer Xotx2, thus reflecting the Xrx1 function
in anterior proliferation. This hypothetical scheme is in
accordance with results from the gene functional ablation (see
next section).
Expression in midbrain-hindbrain boundary of both Xpax2
and En2 as well as rhomboencephalic expression of Krox20 are
found to be repressed in Xrx1-injected tailbud embryos. These
data suggest that the anteriorizing activity of Xrx1 antagonizes
with posteriorizing signals acting in caudal brain regions. This
leads to speculate that, during normal development, Xrx1 might
contribute to exclude the most anterior regions of the neural
plate, where it is expressed, from the range of action of
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posteriorizing signals. Since posteriorizing signals have also
been shown to trigger neuronal differentiation (Papalopulu and
Kintner, 1996), their repression in the anterior neural plate could
represent a basic requirement to allow cell proliferation.
Altogether these results indicate that the proliferative activity of
Xrx1 is linked to the promotion of the anterior fate, in agreement
with other lines of evidence suggesting that mechanisms
regulating cell proliferation-neuronal differentiation interact
with those that control the anterior-posterior patterning
(Papalopulu and Kintner, 1996; Bourguignon et al., 1998).
Anterior deletions in Xrx1-EnR-injected embryos are
due to early loss of the anterior neural plate
territories
In order to perform a loss-of-function analysis of Xrx1, we used
three different approaches. In distinct experiments, we
microinjected Xrx1 antisense RNA, D OAR RNA, coding for a
truncated form of Xrx1 lacking the putative transactivation
domain (OAR motif) and RNA generated from a fusion
construct where the OAR domain was substituted by the
engrailed repressor domain. It is noteworthy that all these
approaches produced similar phenotypes, namely embryos with
anterior deficiencies and reduced or absent eyes, although with
different efficiencies. The fact that D OAR RNA injection does
not generate any of the effects described for full-length Xrx1,
suggests that the OAR motif might be a transactivation domain
as it has been shown to be the case for the Orthopedia protein
(Simeone et al., 1994). Accordingly, the effects observed after
D OAR microinjection may be caused by a passive repression of
Xrx1 target genes. Microinjection of Xrx1-EnR, which is
supposed to actively repress Xrx1 targets, produced very similar
phenotypes but with the highest frequency and penetrance.
Since antisense RNA and Xrx1-EnR injections are supposed to
block Xrx1 function at different independent levels, the
convergence of phenotypes generated by the two different
approaches is a first indication that the observed effects are
specific. The antisense RNA approach has been shown to work
for genes expressed during gastrulation or earlier and, because
of this, the low efficiency that we observed with this method
can be attributed to the relatively late activation of Xrx1
expression. Further support for the specificity of Xrx1-EnR
effects comes from the similarity between Xrx1-EnR and mouse
Rx1 knockout phenotypes (Mathers et al., 1997) and from the
rescue effected by Xrx1 RNA.
To better characterize the affected regions of Xrx1-EnR
embryos, we examined the expression of several anterior
markers, an analysis that was not performed in mouse Rx1 null
mutants. This study indicates that, at tailbud stage, the
telencephalon, ventral diencephalon and eye vesicles have not
formed. Moreover, the strongly reduced expression domains of
Xotx2, Xpax6, Xsix3 and XBF-1 in Xrx1-EnR-injected embryos
already at early neurula stage suggest that the unsuccessful
formation of telencephalic and diencephalic regions occurs
early, when these regions are first specified. Another clue
indicating that Xrx1-EnR is blocking the early function of Xrx1
is provided by the absence of telencephalon in Xrx1-EnR
phenotypes. In fact, Xrx1 is expressed in presumptive
telencephalon at early neurula stage, as shown by
cohybridization with XBF-1 (Fig. 3D), but not at later stages
(Casarosa et al., 1997).
We also noticed that the expression of gsc, an anterior
mesoendodermal marker, is not altered in Xrx1-EnR-injected
embryos indicating that the lack of anterior brain regions is not
caused by the absence of the anterior mesoendoderm. Thus, the
inactivation of Xrx1 function specifically leads to a failure in
the formation of those neuroectodermal regions that normally
express this gene. One exception is perhaps represented by the
pineal gland. Persistence of Xotx-b pineal-gland-specific
expression in Xrx1-EnR-injected embryos, although reduced in
intensity, suggests that Xrx1 may not be required for the
formation of this structure. Alternatively, Xotx-b and Xrx1
might be expressed in different cells within the pineal gland
and only the subset expressing Xrx1 could be affected by Xrx1-
EnR action.
Analysis of Xrx1-EnR activity in animal caps injected with
chordin, which induces a forebrain-like neuralization, basically
confirmed the data obtained in whole embryos. Perhaps more
clearly, animal caps experiments showed that Xrx1-EnR
represses XBF-1 better than Xpax6 while it is not efficient in
blocking Xotx2 transcription. It is interesting to note that, in
the early neurula, while Xrx1 and Xotx2 expression domains
overlap only in a very restricted region, Xrx1 expression
domain shows a good overlapping with that of Xpax6 and
includes the one of XBF-1. Therefore, a possible explanation
for the different responses shown by these genes is that, if Xrx1
plays a role in the specification and/or proliferation of the
neurula territories where it is normally expressed, then the
genes more affected by Xrx1-EnR activity will be the ones
expressed in the same regions.
The nature of the anterior deletions described in Xrx1-EnR-
injected embryos were further analyzed to understand if they
were caused by anterior neuroectoderm posteriorization or by
an early loss of anterior territories. While Xrx1-EnR-injected
embryos did not show any significant change in En2 and Krox20
expression, suggesting that hindbrain territories are normally
specified, a TUNEL staining revealed that early neurulae
displayed accumulation of apoptotic cells restricted to the
anterior part of the embryo. Although these data indicate that
the inhibition of Xrx1 activity generates an early loss of anterior
regions, at the moment it is not clear whether anterior cells die
because of a lack of specification or proliferation, or both. In
any instance, these data suggest that Xrx1 could play a role in
preventing programmed cell death. This hypothesis would not
be in contrast with the previously proposed proliferating activity
of Xrx1 since anterior cells might need to escape programmed
cell death in order to enter a proliferative phase.
In conclusion, we would like to propose that Xrx1 plays an
early role defining forebrain territories in combination with
other homeobox genes expressed in the anterior neural plate.
The function played by Xrx1 in this context is essential for the
development of these regions, as shown by the early loss of
anterior territories in embryos injected with a Xrx1 dominant
repressor construct, and it seems to involve anterior
specification, cell survival and cell proliferation. How these
processes may be linked and temporally regulated remains a
relevant question. Furthermore, investigations aimed at
identifying Xrx1 cofactors and direct targets will be important
to elucidate the molecular mechanisms of anterior neural
patterning.
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